Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Dec;51(12):4285-6.
doi: 10.1128/JCM.02124-13.

Issues on results of the external quality assessment for proviral DNA testing of HIV-1 tropism in the Maraviroc Switch collaborative study

Jörg Berg  1 , Christian Paar, Heribert Stoiber, Thomas Klimkait
Affiliations
Comment

Issues on results of the external quality assessment for proviral DNA testing of HIV-1 tropism in the Maraviroc Switch collaborative study

Jörg Berg et al. J Clin Microbiol. 2013 Dec.
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Tu E, Swenson LC, Land S, Pett S, Emery S, Marks K, Kelleher AD, Kaye S, Kaiser R, Schuelter E, Harrigan R; MARCH Laboratory Group and the MARCH Study Group 2013. Results of external quality assessment for proviral DNA testing of HIV tropism in the Maraviroc Switch Collaborative Study. J. Clin. Microbiol. 51:2063–2071 - PMC - PubMed
    1. McGovern RA, Thielen A, Portsmouth S, Mo T, Dong W, Woods CK, Zhong X, Brumme CJ, Chapman D, Lewis M, James I, Heera J, Valdez H, Harrigan PR. 2012. Population-based sequencing of the V3-loop can predict the virological response to Maraviroc in treatment-naïve patients of the MERIT Trial. J. Acquir. Immune Defic. Syndr. 61:279–286 - PubMed
    1. Svicher V, Alteri C, Montano M, D'Arrigo R, Andreoni M, Angarano G, Antinori A, Antonelli G, Allice T, Bagnarelli P, Baldanti F, Bertoli A, Borderi M, Boeri E, Bon I, Bruzzone B, Callegaro AP, Capobianchi MR, Carosi G, Cauda R, Ceccherini-Silberstein F, Clementi M, Chirianni A, Colafigli M, D'Arminio Monforte A, De Luca A, Di Biagio A, Di Nicuolo G, Di Perri G, Di Pietro M, Di Santo F, Fabeni L, Fadda G, Galli M, Gennari W, Ghisetti V, Giacometti A, Gori C, Gori A, Gulminetti R, Leoncini F, Maffongelli G, Maggiolo F, Manca G, Gargiulo F, Martinelli C, Maserati R, Mazzotta F, Meini G, Micheli V, et al. 2012. Performance testing of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group. New Microbiol. 35:17–25 - PubMed
    1. Paar C, Geit M, Stekel H, Berg J. 2011. Genotypic prediction of human immunodeficiency virus type 1 tropism by use of plasma and peripheral blood mononuclear cells in the routine clinical laboratory. J. Clin. Microbiol. 49:2697–2699 - PMC - PubMed
    1. Svicher V, Cento V, Rozera G, Abbate I, Santoro MM, Armenia D, Fabeni L, Bruselles A, Latini A, Palamara G, Micheli V, Rizzardini G, Gori C, Forbici F, Ippolito G, Andreoni M, Antinori A, Ceccherini-Silberstein F, Capobianchi MR, Perno CF. 2013. The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing. PLoS One 8:e53603.10.1371/journal.pone.0053603 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources